325 CAPITAL LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$349.9M2026 Q3
Positions12
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.97.7%

325 CAPITAL LLC reported 12 positions worth $349.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: MGNI (24.6%).

10 / 12 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 MGNIMagnite$86.2M24.64%3,412,694——+14.0%
▸ 2 ASTHAstrana Health$57.4M16.41%1,613,843——-7.6%
▸ 3 APEIAmerican Public Education$49.9M14.27%1,183,732——-4.0%
▸ 4 BLBDBlue Bird$39.5M11.28%711,390——-0.1%
▸ 5 SPIRSpire Global$33.2M9.48%2,966,932——-22.6%
▸ 6 MPAAMotorcar Parts of$21.2M6.05%2,018,795——-27.3%
▸ 7 LFCRLifecore Biomedical$19.1M5.45%2,895,881———
▸ 8 AIOTPowerfleet$15.0M4.29%5,283,000——-14.4%
▸ 9 DBDDiebold Nixdorf$14.8M4.24%242,084——-3.4%
▸ 10 BTMDbiote$5.5M1.57%4,548,127——-14.9%

Pro Feature

The remaining 2 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does 325 CAPITAL LLC hold as of Q3 2026?

325 CAPITAL LLC reported 12 positions worth $349.9M in its Q3 2026 13F filing. Largest positions: MGNI (24.6%), ASTH (16.4%), APEI (14.3%), BLBD (11.3%) and SPIR (9.5%).

What did 325 CAPITAL LLC buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did 325 CAPITAL LLC sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.